| 臺大學術典藏 |
2022-01-12T07:07:20Z |
Dynamics of DNMT3A mutation and prognostic relevance in patients with primary myelodysplastic syndrome
|
Lin M.-E.; HSIN-AN HOU; Tsai C.-H.; Wu S.-J.; Kuo Y.-Y.; Tseng M.-H.; Liu M.-C.; Liu C.-W.; Chou W.-C.; Chen C.-Y.; Tang J.-L.; Yao M.; Li C.-C.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Lin C.-T.; Tien H.-F. |
| 臺大學術典藏 |
2022-01-12T07:07:20Z |
Prognostic impacts and dynamic changes of cohesin complex gene mutations in de novo acute myeloid leukemia
|
Tsai C.-H.; HSIN-AN HOU; Tang J.-L.; Kuo Y.-Y.; Chiu Y.-C.; Lin C.-C.; Liu C.-Y.; Tseng M.-H.; Lin T.-Y.; Liu M.-C.; Liu C.-W.; Lin L.-I.; Yao M.; Li C.-C.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Lin C.-T.; Wu S.-J.; Chen C.-Y.; Tsay W.; Chuang E.Y.; Chou W.-C.; Tien H.-F. |
| 臺大學術典藏 |
2022-01-12T07:07:20Z |
Incorporation of mutations in five genes in the revised International Prognostic Scoring System can improve risk stratification in the patients with myelodysplastic syndrome
|
HSIN-AN HOU; Tsai C.-H.; Lin C.-C.; Chou W.-C.; Kuo Y.-Y.; Liu C.-Y.; Tseng M.-H.; Peng Y.-L.; Liu M.-C.; Liu C.-W.; Liao X.-W.; Lin L.-I.; Yao M.; Tang J.-L.; Tien H.-F. |
| 臺大學術典藏 |
2022-01-12T07:07:19Z |
Epidemiology of multiple myeloma in Taiwan, a population based study
|
Tang C.-H.; Liu H.-Y.; HSIN-AN HOU; Qiu H.; Huang K.-C.; Siggins S.; Rothwell L.A.; Liu Y. |
| 臺大學術典藏 |
2022-01-12T07:07:19Z |
Expression of mutant Asxl1 perturbs hematopoiesis and promotes susceptibility to leukemic transformation
|
Nagase R.; Inoue D.; Pastore A.; Fujino T.; HSIN-AN HOU; Yamasaki N.; Goyama S.; Saika M.; Kanai A.; Sera Y.; Horikawa S.; Ota Y.; Asada S.; Hayashi Y.; Kawabata K.C.; Takeda R.; Tien H.-F.; Honda H.; Abdel-Wahab O.; Kitamura T. |
| 臺大學術典藏 |
2022-01-12T07:07:19Z |
Hyperleukocytosis is associated with distinct genetic alterations and is an independent poor-risk factor in de novo acute myeloid leukemia patients
|
Tien F.-M.; HSIN-AN HOU; Tsai C.-H.; Tang J.-L.; Chen C.-Y.; Kuo Y.-Y.; Li C.-C.; Lin C.-T.; Yao M.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Tsay W.; Tseng M.-H.; Liu M.-C.; Liu C.-W.; Lin L.-I.; Chou W.-C.; Tien H.-F. |
| 臺大學術典藏 |
2022-01-12T07:07:18Z |
GATA2 zinc finger 1 mutations are associated with distinct clinico-biological features and outcomes different from GATA2 zinc finger 2 mutations in adult acute myeloid leukemia
|
Tien F.-M.; HSIN-AN HOU; Tsai C.-H.; Tang J.-L.; Chiu Y.-C.; Chen C.-Y.; Kuo Y.-Y.; Tseng M.-H.; Peng Y.-L.; Liu M.-C.; Liu C.-W.; Liao X.-W.; Lin L.-I.; Lin C.-T.; Wu S.-J.; Ko B.-S.; Hsu S.-C.; Huang S.-Y.; Yao M.; Chou W.-C.; Tien H.-F. |
| 臺大學術典藏 |
2022-01-12T07:07:18Z |
The prognostic significance of global aberrant alternative splicing in patients with myelodysplastic syndrome
|
Yang Y.-T.; Chiu Y.-C.; Kao C.-J.; HSIN-AN HOU; Lin C.-C.; Tsai C.-H.; Tseng M.-H.; Chou W.-C.; Tien H.-F. |
| 臺大學術典藏 |
2022-01-12T07:07:17Z |
Concomitant WT1 mutations predict poor prognosis in acute myeloid leukemia patients with double mutant CEBPA
|
Tien F.-M.; HSIN-AN HOU; Tang J.-L.; Kuo Y.-Y.; Chen C.-Y.; Tsai C.-H.; Yao M.; Lin C.-T.; Li C.-C.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Liu J.-H.; Chou S.-C.; Tsay W.; Tseng M.-H.; Liu M.-C.; Liu C.-W.; Lin L.-I.; Chou W.-C.; Tien H.-F. |
| 臺大學術典藏 |
2022-01-12T07:07:17Z |
Mayo Alliance Prognostic Model for Myelodysplastic Syndromes: Integration of Genetic and Clinical Information
|
Tefferi A.; Gangat N.; Mudireddy M.; Lasho T.L.; Finke C.; Begna K.H.; Elliott M.A.; Al-Kali A.; Litzow M.R.; Hook C.C.; Wolanskyj A.P.; Hogan W.J.; Patnaik M.M.; Pardanani A.; Zblewski D.L.; He R.; Viswanatha D.; Hanson C.A.; Ketterling R.P.; Tang J.-L.; Chou W.-C.; Lin C.-C.; Tsai C.-H.; Tien H.-F.; HSIN-AN HOU |
| 臺大學術典藏 |
2022-01-12T07:07:16Z |
Phf6-null hematopoietic stem cells have enhanced self-renewal capacity and oncogenic potentials
|
Hsu Y.-C.; Chen T.-C.; Lin C.-C.; Yuan C.-T.; Hsu C.-L.; HSIN-AN HOU; Kao C.-J.; Chuang P.-H.; Chen Y.-R.; Chou W.-C.; Tien H.-F. |
| 臺大學術典藏 |
2022-01-12T07:07:16Z |
Clinically validated machine learning algorithm for detecting residual diseases with multicolor flow cytometry analysis in acute myeloid leukemia and myelodysplastic syndrome
|
Ko B.-S.; Wang Y.-F.; Li J.-L.; Li C.-C.; Weng P.-F.; Hsu S.-C.; HSIN-AN HOU; Huang H.-H.; Yao M.; Lin C.-T.; Liu J.-H.; Tsai C.-H.; Huang T.-C.; Wu S.-J.; Huang S.-Y.; Chou W.-C.; Tien H.-F.; Lee C.-C.; Tang J.-L. |
| 臺大學術典藏 |
2022-01-12T07:07:15Z |
Incorporation of long non-coding RNA expression profile in the 2017 ELN risk classification can improve prognostic prediction of acute myeloid leukemia patients
|
Tsai C.-H.; Yao C.-Y.; Tien F.-M.; Tang J.-L.; Kuo Y.-Y.; Chiu Y.-C.; Lin C.-C.; Tseng M.-H.; Peng Y.-L.; Liu M.-C.; Liu C.-W.; Yao M.; Lin L.-I.; Chou W.-C.; Chen C.-Y.; HSIN-AN HOU; Tien H.-F. |
| 臺大學術典藏 |
2022-01-12T07:07:15Z |
Non-del(5q) myelodysplastic syndromes–associated loci detected by SNP-array genome-wide association meta-analysis
|
McGraw K.L.; Cheng C.-H.; Chen Y.A.; HSIN-AN HOU; Nilsson B.; Genovese G.; Cluzeau T.; Pellagatti A.; Przychodzen B.P.; Mallo M.; Arenillas L.; Mohamedali A.; Adès L.; Sallman D.A.; Padron E.; Sokol L.; Moreilhon C.; Raynaud S.; Tien H.-F.; Boultwood J.; Ebert B.L.; Sole F.; Fenaux P.; Mufti G.J.; Maciejewski J.P.; Kanetsky P.A.; List A.F. |
| 臺大學術典藏 |
2022-01-12T07:07:14Z |
Long non-coding RNA HOXB-AS3 promotes myeloid cell proliferation and its higher expression is an adverse prognostic marker in patients with acute myeloid leukemia and myelodysplastic syndrome
|
Huang H.-H.; Chen F.-Y.; Chou W.-C.; HSIN-AN HOU; Ko B.-S.; Lin C.-T.; Tang J.-L.; Li C.-C.; Yao M.; Tsay W.; Hsu S.-C.; Wu S.-J.; Chen C.-Y.; Huang S.-Y.; Tseng M.-H.; Tien H.-F.; Chen R.-H. |
| 臺大學術典藏 |
2022-01-12T07:07:14Z |
Genomic landscape and clonal evolution of acute myeloid leukemia with t(8;21): An international study on 331 patients
|
Christen F.; Hoyer K.; Yoshida K.; HSIN-AN HOU; Waldhueter N.; Heuser M.; Hills R.K.; Chan W.; Hablesreiter R.; Blau O.; Ochi Y.; Klement P.; Chou W.-C.; Blau I.-W.; Tang J.-L.; Zemojtel T.; Shiraishi Y.; Shiozawa Y.; Thol F.; Ganser A.; Löwenberg B.; Linch D.C.; Bullinger L.; Valk P.J.M.; Tien H.-F.; Gale R.E.; Ogawa S.; Damm F. |
| 臺大學術典藏 |
2022-01-12T07:07:14Z |
Adoptive donor immunity protects against resolved hepatitis B virus reactivation after allogeneic haematopoietic stem cell transplantation in the world's largest retrospective cohort study
|
Liu J.-H.; Liao X.-W.; Chen C.-H.; Yao M.; Li C.-C.; Lin C.-T.; Tsai C.-H.; Chou W.-C.; HSIN-AN HOU; Huang S.-Y.; Wu S.-J.; Chen Y.-C.; Tien H.-F.; Tang J.-L.; Ko B.-S. |
| 臺大學術典藏 |
2022-01-12T07:07:13Z |
A 4-gene leukemic stem cell score can independently predict the prognosis of myelodysplastic syndrome patients
|
Wang Y.-H.; Lin C.-C.; Yao C.-Y.; Hsu C.-L.; HSIN-AN HOU; Tsai C.-H.; Chou W.-C.; Tien H.-F. |
| 臺大學術典藏 |
2022-01-12T07:07:13Z |
Treatment evolution and improved survival in multiple myeloma in Taiwan
|
Tang C.-H.; HSIN-AN HOU; Huang K.-C.; Qiu H.; Liu Y. |
| 臺大學術典藏 |
2022-01-12T07:07:12Z |
Cytogenetics and mutations could predict outcome in relapsed and refractory acute myeloid leukemia patients receiving BCL-2 inhibitor venetoclax
|
Wang Y.-W.; Tsai C.-H.; Lin C.-C.; Tien F.-M.; Chen Y.-W.; Lin H.-Y.; Yao M.; Lin Y.-C.; Lin C.-T.; Cheng C.-L.; Tang J.-L.; Chou W.-C.; HSIN-AN HOU; Tien H.-F. |
| 臺大學術典藏 |
2022-01-12T07:07:12Z |
Knock-out of Hopx disrupts stemness and quiescence of hematopoietic stem cells in mice
|
Lin C.-C.; Yao C.-Y.; Hsu Y.-C.; HSIN-AN HOU; Yuan C.-T.; Li Y.-H.; Kao C.-J.; Chuang P.-H.; Chiu Y.-C.; Chen Y.; Chou W.-C.; Tien H.-F. |
| 臺大學術典藏 |
2022-01-12T07:07:12Z |
Genomic landscape in acute myeloid leukemia and its implications in risk classification and targeted therapies
|
HSIN-AN HOU; Tien H.-F. |
| 臺大學術典藏 |
2022-01-12T07:07:12Z |
MERGE: A Multinational, Multicenter Observational Registry for Myeloproliferative Neoplasms in Asia, including Middle East, Turkey, and Algeria
|
Yassin M.A.; Taher A.; Mathews V.; HSIN-AN HOU; Shamsi T.; Tuğlular T.F.; Xiao Z.; Kim S.-J.; Depei W.; Li J.; Rippin G.; Sadek I.; Siddiqui A.; Wong R.S. |
| 臺大學術典藏 |
2022-01-12T07:07:11Z |
TP53 mutations in myelodysplastic syndromes and secondary AML confer an immunosuppressive phenotype
|
Sallman D.A.; McLemore A.F.; Aldrich A.L.; Komrokji R.S.; McGraw K.L.; Dhawan A.; Geyer S.; HSIN-AN HOU; Eksioglu E.A.; Sullivan A.; Warren S.; MacBeth K.J.; Meggendorfer M.; Haferlach T.; Boettcher S.; Ebert B.L.; Al Ali N.H.; Lancet J.E.; Cleveland J.L.; Padron E.; List A.F. |
| 臺大學術典藏 |
2022-01-12T07:07:11Z |
Is the risk of second primary malignancy increased in multiple myeloma in the novel therapy era? A population-based, retrospective cohort study in Taiwan
|
Liu Y.; HSIN-AN HOU; Qiu H.; Tang C.-H. |
| 臺大學術典藏 |
2022-01-12T07:07:11Z |
ASXL1 mutation confers poor prognosis in primary myelofibrosis patients with low JAK2V617F allele burden but not in those with high allele burden
|
Wang Y.-H.; Lin C.-C.; Lee S.-H.; Tsai C.-H.; Wu S.-J.; HSIN-AN HOU; Huang T.-C.; Kuo Y.-Y.; Yao M.; Chang K.; Lin C.-W.; Lin Y.-C.; Tien F.-M.; Chou W.-C.; Tang J.-L.; Tien H.-F. |
| 臺大學術典藏 |
2022-01-12T07:07:10Z |
Distinct clinico-biological features in AML patients with low allelic ratio FLT3-ITD: role of allogeneic stem cell transplantation in first remission
|
Tien F.-M.; Tsai C.-H.; Huang S.-C.; Liu J.-H.; Chen C.-Y.; Kuo Y.-Y.; Chuang Y.-K.; Tseng M.-H.; Peng Y.-L.; Liu M.-C.; Liu C.-W.; Liao X.-W.; Lin L.-I.; Wu Y.-S.; Hou M.-F.; Wu S.-J.; Hsu S.-C.; Ko B.-S.; Chou W.-C.; Yao M.; HSIN-AN HOU; Tang J.-L.; Tien H.-F. |
| 臺大學術典藏 |
2022-01-12T07:07:10Z |
Repurposing cabozantinib with therapeutic potential in KIT-driven t(8;21) acute myeloid leukaemias
|
Su K.-W.; Ou D.-L.; Fu Y.-H.; Tien H.-F.; HSIN-AN HOU; Lin L.-I. |
| 臺大學術典藏 |
2022-01-12T07:07:09Z |
Distinct clinical and biological characteristics of acute myeloid leukemia with higher expression of long noncoding RNA KIAA0125
|
Wang Y.-H.; Lin C.-C.; Hsu C.-L.; Hung S.-Y.; Yao C.-Y.; Lee S.-H.; Tsai C.-H.; HSIN-AN HOU; Chou W.-C.; Tien H.-F. |
| 臺大學術典藏 |
2022-01-12T07:07:09Z |
Polatuzumab vedotin–based salvage immunochemotherapy as third-line or beyond treatment for patients with diffuse large B-cell lymphoma: a real-world experience
|
Wang Y.-W.; Tsai X.C.-H.; HSIN-AN HOU; Tien F.-M.; Liu J.-H.; Chou W.-C.; Ko B.-S.; Chen Y.-W.; Lin C.-C.; Cheng C.-L.; Lo M.-Y.; Lin Y.-C.; Lu L.-C.; Wu S.-J.; Kuo S.-H.; Hong R.-L.; Huang T.-C.; Yao M. |
| 臺大學術典藏 |
2022-01-12T07:07:08Z |
TFEB Links MYC Signaling to Epigenetic Control of Myeloid Differentiation and Acute Myeloid Leukemia
|
Yun S.; Vincelette N.D.; Yu X.; Watson G.W.; Fernandez M.R.; Yang C.; Hitosugi T.; Cheng C.-H.; Freischel A.R.; Zhang L.; Li W.; HSIN-AN HOU; Schaub F.X.; Vedder A.R.; Cen L.; McGraw K.L.; Moon J.; Murphy D.J.; Ballabio A.; Kaufmann S.H.; Berglund A.E.; Cleveland J.L. |
| 臺大學術典藏 |
2022-01-12T07:07:08Z |
The expression levels of long non-coding RNA KIAA0125 are associated with distinct clinical and biological features in myelodysplastic syndromes
|
Hung S.-Y.; Lin C.-C.; Hsu C.-L.; Yao C.-Y.; Wang Y.-H.; Tsai C.-H.; HSIN-AN HOU; Chou W.-C.; Tien H.-F. |
| 臺大學術典藏 |
2022-01-12T07:07:07Z |
Treatment pathways and disease journeys differ before and after introduction of novel agents in newly diagnosed multiple myeloma in Taiwan
|
Liu Y.; Tang C.-H.; Qiu H.; Siggins S.; HSIN-AN HOU |
| 臺大學術典藏 |
2022-01-12T07:07:07Z |
A CIBERSORTx-based immune cell scoring system could independently predict the prognosis of patients with myelodysplastic syndromes
|
Wang Y.-H.; HSIN-AN HOU; Lin C.-C.; Kuo Y.-Y.; Yao C.-Y.; Hsu C.-L.; Tseng M.-H.; Tsai C.-H.; Peng Y.-L.; Kao C.-J.; Chou W.-C.; Tien H.-F. |
| 臺大學術典藏 |
2022-01-12T07:07:07Z |
Clinical implications of sequential MRD monitoring by NGS at 2 time points after chemotherapy in patients with AML
|
Tsai C.-H.; Tang J.-L.; Tien F.-M.; Kuo Y.-Y.; Wu D.-C.; Lin C.-C.; Tseng M.-H.; Peng Y.-L.; Hou M.-F.; Chuang Y.-K.; Liu M.-C.; Liu C.-W.; Yao M.; Lin L.-I.; Chou W.-C.; Chen C.-Y.; HSIN-AN HOU; Tien H.-F. |
| 臺大學術典藏 |
2022-01-12T07:07:06Z |
Clinical outcomes of intravitreal methotrexate injection protocol with a reduced initial frequency for intraocular lymphoma
|
Hsu C.-J.; HSIN-AN HOU; Lin C.-P.; Lee Y.-J.; Hsu W.-F.; Yeh P.-T. |
| 臺大學術典藏 |
2022-01-12T07:07:06Z |
PD-L1 expression in megakaryocytes and its clinicopathological features in primary myelofibrosis patients
|
Lee S.-H.; Lin C.-C.; Wei C.-H.; Chang K.-P.; Yuan C.-T.; Tsai C.-H.; Liu J.-H.; HSIN-AN HOU; Tang J.-L.; Chou W.-C.; Tien H.-F. |
| 臺大學術典藏 |
2022-01-12T07:07:05Z |
Effectiveness of induction regimens on survival outcome in acute myeloid leukemia patients: a real-world data from 2001 to 2015
|
HSIN-AN HOU; Tzeng H.-E.; Liu H.-Y.; Chou W.-C.; Tien H.-F.; Chien L.-N. |
| 臺大學術典藏 |
2022-01-12T07:07:05Z |
Immune signatures of bone marrow cells can independently predict prognosis in patients with myelodysplastic syndrome
|
Wang Y.-H.; Lin C.-C.; Yao C.-Y.; Hsu C.-L.; Tsai C.-H.; HSIN-AN HOU; Chou W.-C.; Tien H.-F. |
| 臺大學術典藏 |
2022-01-10T08:54:12Z |
Clinical implications of sequential MRD monitoring by NGS at 2 time points after chemotherapy in patients with AML
|
CHENG-HONG TSAI; JIH-LUH TANG; Tien, Feng Ming; YUAN-YEH KUO; Wu, Dung Chi; CHIEN-CHIN LIN; Tseng, Mei Hsuan; Peng, Yen Ling; Hou, Mei Fang; Chuang, Yi Kuang; Liu, Ming Chih; CHIA-WEN LIU; MING YAO; LIANG-IN LIN; WEN-CHIEN CHOU; CHIEN-YU CHEN; HSIN-AN HOU; HWEI-FANG TIEN |
| 臺大學術典藏 |
2021-12-14T23:12:05Z |
A CIBERSORTx-based immune cell scoring system could independently predict the prognosis of patients with myelodysplastic syndromes
|
Wang, Yu Hung; HSIN-AN HOU; CHIEN-CHIN LIN; YUAN-YEH KUO; CHI-YUAN YAO; CHIA-LANG HSU; Tseng, Mei Hsuan; CHENG-HONG TSAI; Peng, Yen Ling; Kao, Chein Jun; WEN-CHIEN CHOU; HWEI-FANG TIEN |
| 臺大學術典藏 |
2021-11-21T23:19:44Z |
Polatuzumab vedotin–based salvage immunochemotherapy as third-line or beyond treatment for patients with diffuse large B-cell lymphoma: a real-world experience
|
Wang, Yu Wen; Tsai, Xavier Cheng Hong; HSIN-AN HOU; Tien, Feng Ming; Liu, Jia Hau; WEN-CHIEN CHOU; BOR-SHENG KO; YU-WEN CHEN; CHIEN-CHIN LIN; Cheng, Chieh Lung; Lo, Min Yen; Lin, Yun Chu; Lu, Li Chun; SHANG-JU WU; SUNG-HSIN KUO; Hong, Ruey Long; TAI-CHUNG HUANG; MING YAO |
| 臺大學術典藏 |
2021-11-21T23:19:35Z |
Distinct clinico-biological features in AML patients with low allelic ratio FLT3-ITD: role of allogeneic stem cell transplantation in first remission
|
Tien, Feng Ming; CHENG-HONG TSAI; Huang, Sheng Chuan; Liu, Jia Hau; Chen, Chien-Yuan; YUAN-YEH KUO; Chuang, Yi Kuang; Tseng, Mei Hsuan; Peng, Yen Ling; Liu, Ming Chih; CHIA-WEN LIU; Liao, Xiu Wen; LIANG-IN LIN; Wu, Yu Sin; Hou, Mei Fang; SHANG-JU WU; SZU-CHUN HSU; BOR-SHENG KO; WEN-CHIEN CHOU; MING YAO; HSIN-AN HOU; JIH-LUH TANG; HWEI-FANG TIEN |
| 臺大學術典藏 |
2021-10-21T23:27:14Z |
Immune signatures of bone marrow cells can independently predict prognosis in patients with myelodysplastic syndrome
|
Wang, Yu Hung; CHIEN-CHIN LIN; Yao, Chi Yuan; CHIA-LANG HSU; CHENG-HONG TSAI; HSIN-AN HOU; WEN-CHIEN CHOU; HWEI-FANG TIEN |
| 臺大學術典藏 |
2021-09-14T23:18:36Z |
PD-L1 expression in megakaryocytes and its clinicopathological features in primary myelofibrosis patients
|
Lee, Sze Hwei; CHIEN-CHIN LIN; Wei, Chao Hong; Chang, Ko Ping; Yuan, Chang Tsu; CHENG-HONG TSAI; Liu, Jia Hao; HSIN-AN HOU; Tang, Jih Lu; WEN-CHIEN CHOU; HWEI-FANG TIEN |
| 臺大學術典藏 |
2021-07-15T05:32:24Z |
Clinical outcomes of intravitreal methotrexate injection protocol with a reduced initial frequency for intraocular lymphoma
|
Hsu, Chiung Ju; HSIN-AN HOU; CHANG-PING LIN; Lee, Yi Jui; Hsu, Wen Fang; PO-TING YEH |
| 臺大學術典藏 |
2021-07-15T05:31:45Z |
Clinical implications of sequential MRD monitoring by NGS at 2 time points after chemotherapy in patients with AML
|
CHENG-HONG TSAI; JIH-LUH TANG; Tien, Feng Ming; YUAN-YEH KUO; Wu, Dung Chi; CHIEN-CHIN LIN; Tseng, Mei Hsuan; Peng, Yen Ling; Hou, Mei Fang; Chuang, Yi Kuang; Liu, Ming Chih; CHIA-WEN LIU; MING YAO; LIANG-IN LIN; WEN-CHIEN CHOU; CHIEN-YU CHEN; HSIN-AN HOU; HWEI-FANG TIEN |
| 臺大學術典藏 |
2021-05-21T11:40:30Z |
Repurposing cabozantinib with therapeutic potential in KIT-driven t(8;21) acute myeloid leukaemias
|
Su, Kuan Wei; DA-LIANG OU; Fu, Yu Hsuan; HWEI-FANG TIEN; HSIN-AN HOU; LIANG-IN LIN |
| 臺大學術典藏 |
2021-03-02T14:00:05Z |
Treatment pathways and disease journeys differ before and after introduction of novel agents in newly diagnosed multiple myeloma in Taiwan
|
Liu, Yanfang; Tang, Chao Hsiun; Qiu, Hong; Siggins, Sarah; HSIN-AN HOU |
| 臺大學術典藏 |
2020-10-28T02:42:55Z |
ASXL1 mutation confers poor prognosis in primary myelofibrosis patients with low JAK2V617F allele burden but not in those with high allele burden
|
Wang, Yu-Hung; JIH-LUH TANG; Lee, Sze-Hwei; CHENG-HONG TSAI; Wu, Shan-Ju; HSIN-AN HOU; TAI-CHUNG HUANG; YUAN-YEH KUO; MING YAO; Chang, Koping; CHUNG-WU LIN; Lin, Yun-Chu; Tien, Fen-Ming; Chou, Wen-Chien; HWEI-FANG TIEN; CHIEN-CHIN LIN |
